APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cold and Flu Supplement

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cold and Flu Supplement Market Analysis and Forecast 2026-2032

Report ID 173979390220 December 2025191 pages

Choose your research edition.

Industry ResearchCold and Flu Supplement Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cold and Flu Supplement Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Cold and Flu Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cold and Flu Supplement Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cold and Flu Supplement Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Cold and Flu Supplement market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cold and Flu Supplement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cold and Flu Supplement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cold and Flu Supplement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cold and Flu Supplement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cold and Flu Supplement include Pfizer, GlaxoSmithKline, Wakunaga of America, The Vitamin Shoppe, NOW Foods, Nordic Naturals, Neurobiologix, Klaire Labs and Himalaya Global Holdings, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cold and Flu Supplement, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cold and Flu Supplement, also provides the revenue of main regions and countries. Of the upcoming market potential for Cold and Flu Supplement, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cold and Flu Supplement revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cold and Flu Supplement market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cold and Flu Supplement revenue, projected growth trends, production technology, application and end-user industry.

Cold and Flu Supplement Segment by Company

Pfizer

GlaxoSmithKline

Wakunaga of America

The Vitamin Shoppe

NOW Foods

Nordic Naturals

Neurobiologix

Klaire Labs

Himalaya Global Holdings

Flora

FineVine

Dr. Willmar Schwabe GmbH

Cold and Flu Supplement Segment by Type

Herbal Extracts

Natural Molecules

Vitamins and Minerals

Others

Cold and Flu Supplement Segment by Application

Online

Offline

Cold and Flu Supplement Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cold and Flu Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cold and Flu Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cold and Flu Supplement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cold and Flu Supplement in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cold and Flu Supplement company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cold and Flu Supplement revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cold and Flu Supplement Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Herbal Extracts Major Player Table 3. Natural Molecules Major Player Table 4. Vitamins and Minerals Major Player Table 5. Others Major Player Table 6. Global Cold and Flu Supplement Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Online Major Player Table 8. Offline Major Player Table 9. Cold and Flu Supplement Industry Trends Table 10. Cold and Flu Supplement Industry Drivers Table 11. Cold and Flu Supplement Industry Opportunities and Challenges Table 12. Cold and Flu Supplement Industry Restraints Table 13. Global Cold and Flu Supplement Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Cold and Flu Supplement Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Cold and Flu Supplement Market Share by Region (2021-2026) Table 16. Global Cold and Flu Supplement Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Cold and Flu Supplement Market Share by Region (2027-2032) Table 18. Global Cold and Flu Supplement Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Cold and Flu Supplement Revenue Market Share by Players (2021-2026) Table 20. Global Cold and Flu Supplement Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Cold and Flu Supplement Key Players Headquarters & Area Served Table 22. Global Cold and Flu Supplement Players, Product Type & Application Table 23. Global Cold and Flu Supplement Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Cold and Flu Supplement by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Cold and Flu Supplement Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cold and Flu Supplement Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Cold and Flu Supplement Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Cold and Flu Supplement Revenue Market Share by Type (2021-2026) Table 30. Global Cold and Flu Supplement Revenue Market Share by Type (2027-2032) Table 31. Global Cold and Flu Supplement Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Cold and Flu Supplement Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Cold and Flu Supplement Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Cold and Flu Supplement Revenue Market Share by Application (2021-2026) Table 35. Global Cold and Flu Supplement Revenue Market Share by Application (2027-2032) Table 36. Pfizer Company Information Table 37. Pfizer Business Overview Table 38. Pfizer Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Pfizer Cold and Flu Supplement Product Portfolio Table 40. Pfizer Recent Development Table 41. GlaxoSmithKline Company Information Table 42. GlaxoSmithKline Business Overview Table 43. GlaxoSmithKline Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. GlaxoSmithKline Cold and Flu Supplement Product Portfolio Table 45. GlaxoSmithKline Recent Development Table 46. Wakunaga of America Company Information Table 47. Wakunaga of America Business Overview Table 48. Wakunaga of America Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Wakunaga of America Cold and Flu Supplement Product Portfolio Table 50. Wakunaga of America Recent Development Table 51. The Vitamin Shoppe Company Information Table 52. The Vitamin Shoppe Business Overview Table 53. The Vitamin Shoppe Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. The Vitamin Shoppe Cold and Flu Supplement Product Portfolio Table 55. The Vitamin Shoppe Recent Development Table 56. NOW Foods Company Information Table 57. NOW Foods Business Overview Table 58. NOW Foods Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. NOW Foods Cold and Flu Supplement Product Portfolio Table 60. NOW Foods Recent Development Table 61. Nordic Naturals Company Information Table 62. Nordic Naturals Business Overview Table 63. Nordic Naturals Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Nordic Naturals Cold and Flu Supplement Product Portfolio Table 65. Nordic Naturals Recent Development Table 66. Neurobiologix Company Information Table 67. Neurobiologix Business Overview Table 68. Neurobiologix Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Neurobiologix Cold and Flu Supplement Product Portfolio Table 70. Neurobiologix Recent Development Table 71. Klaire Labs Company Information Table 72. Klaire Labs Business Overview Table 73. Klaire Labs Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Klaire Labs Cold and Flu Supplement Product Portfolio Table 75. Klaire Labs Recent Development Table 76. Himalaya Global Holdings Company Information Table 77. Himalaya Global Holdings Business Overview Table 78. Himalaya Global Holdings Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Himalaya Global Holdings Cold and Flu Supplement Product Portfolio Table 80. Himalaya Global Holdings Recent Development Table 81. Flora Company Information Table 82. Flora Business Overview Table 83. Flora Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Flora Cold and Flu Supplement Product Portfolio Table 85. Flora Recent Development Table 86. FineVine Company Information Table 87. FineVine Business Overview Table 88. FineVine Cold and Flu Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. FineVine Cold and Flu Supplement Product Portfolio Table 90. FineVine Recent Development Table 91. Dr. Willmar Schwabe GmbH Company Information Table 92. Dr. Willmar Schwabe GmbH Business Overview Table 93. Dr. Willmar Schwabe GmbH Cold and Flu Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Dr. Willmar Schwabe GmbH Cold and Flu Supplement Product Portfolio Table 95. Dr. Willmar Schwabe GmbH Recent Development Table 96. North America Cold and Flu Supplement Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Cold and Flu Supplement Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Cold and Flu Supplement Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Cold and Flu Supplement Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Cold and Flu Supplement Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Cold and Flu Supplement Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Cold and Flu Supplement Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Cold and Flu Supplement Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Cold and Flu Supplement Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Cold and Flu Supplement Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Cold and Flu Supplement Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Cold and Flu Supplement Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Cold and Flu Supplement Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Cold and Flu Supplement Revenue by Country (US$ Million) & (2027-2032) Table 110. China Cold and Flu Supplement Revenue by Type (2021-2026) & (US$ Million) Table 111. China Cold and Flu Supplement Revenue by Type (2027-2032) & (US$ Million) Table 112. China Cold and Flu Supplement Revenue by Application (2021-2026) & (US$ Million) Table 113. China Cold and Flu Supplement Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Cold and Flu Supplement Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Cold and Flu Supplement Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Cold and Flu Supplement Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Cold and Flu Supplement Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Cold and Flu Supplement Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Cold and Flu Supplement Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Cold and Flu Supplement Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Cold and Flu Supplement Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Cold and Flu Supplement Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Cold and Flu Supplement Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Cold and Flu Supplement Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Cold and Flu Supplement Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Cold and Flu Supplement Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Cold and Flu Supplement Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Cold and Flu Supplement Image Figure 2. Global Cold and Flu Supplement Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cold and Flu Supplement Market Size Share 2021 VS 2025 VS 2032 Figure 4. Herbal Extracts Image Figure 5. Natural Molecules Image Figure 6. Vitamins and Minerals Image Figure 7. Others Image Figure 8. Global Cold and Flu Supplement Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Cold and Flu Supplement Market Size Share 2021 VS 2025 VS 2032 Figure 10. Online Image Figure 11. Offline Image Figure 12. Global Cold and Flu Supplement Market Size (US$ Million) & (2021-2032) Figure 13. Global Cold and Flu Supplement Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Cold and Flu Supplement Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Cold and Flu Supplement Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Cold and Flu Supplement Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Cold and Flu Supplement Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Cold and Flu Supplement Revenue Market Share by Type (2021-2032) Figure 20. Global Cold and Flu Supplement Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cold and Flu Supplement Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Cold and Flu Supplement Revenue Market Share by Application (2021-2032) Figure 23. North America Cold and Flu Supplement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Cold and Flu Supplement Revenue Share by Type (2021-2032) Figure 25. North America Cold and Flu Supplement Revenue Share by Application (2021-2032) Figure 26. North America Cold and Flu Supplement Revenue Share by Country (2021-2032) Figure 27. United States Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Cold and Flu Supplement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Cold and Flu Supplement Revenue Share by Type (2021-2032) Figure 32. Europe Cold and Flu Supplement Revenue Share by Application (2021-2032) Figure 33. Europe Cold and Flu Supplement Revenue Share by Country (2021-2032) Figure 34. Germany Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Cold and Flu Supplement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Cold and Flu Supplement Revenue Share by Type (2021-2032) Figure 44. China Cold and Flu Supplement Revenue Share by Application (2021-2032) Figure 45. Asia Cold and Flu Supplement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Cold and Flu Supplement Revenue Share by Type (2021-2032) Figure 47. Asia Cold and Flu Supplement Revenue Share by Application (2021-2032) Figure 48. Asia Cold and Flu Supplement Revenue Share by Region (2021-2032) Figure 49. Japan Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Cold and Flu Supplement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Cold and Flu Supplement Revenue Share by Type (2021-2032) Figure 57. SAMEA Cold and Flu Supplement Revenue Share by Application (2021-2032) Figure 58. SAMEA Cold and Flu Supplement Revenue Share by Country (2021-2032) Figure 59. Brazil Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Cold and Flu Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Herbal Extracts
  • Natural Molecules
  • Vitamins and Minerals
  • Others
Applications
  • Online
  • Offline
Companies covered
  • Pfizer
  • GlaxoSmithKline
  • Wakunaga of America
  • The Vitamin Shoppe
  • NOW Foods
  • Nordic Naturals
  • Neurobiologix
  • Klaire Labs
  • Himalaya Global Holdings
  • Flora
  • FineVine
  • Dr. Willmar Schwabe GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cold and Flu Supplement Market by Type
  3. 1.2.1 Global Cold and Flu Supplement Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Herbal Extracts
  5. 1.2.3 Natural Molecules
  6. 1.2.4 Vitamins and Minerals
  7. 1.2.5 Others
  8. 1.3 Cold and Flu Supplement Market by Application
  9. 1.3.1 Global Cold and Flu Supplement Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Online
  11. 1.3.3 Offline
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Cold and Flu Supplement Market Dynamics
  1. 2.1 Cold and Flu Supplement Industry Trends
  2. 2.2 Cold and Flu Supplement Industry Drivers
  3. 2.3 Cold and Flu Supplement Industry Opportunities and Challenges
  4. 2.4 Cold and Flu Supplement Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cold and Flu Supplement Market Perspective (2021-2032)
  2. 3.2 Global Cold and Flu Supplement Growth Trends by Region
  3. 3.2.1 Global Cold and Flu Supplement Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cold and Flu Supplement Market Size by Region (2021-2026)
  5. 3.2.3 Global Cold and Flu Supplement Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cold and Flu Supplement Revenue by Players
  2. 4.1.1 Global Cold and Flu Supplement Revenue by Players (2021-2026)
  3. 4.1.2 Global Cold and Flu Supplement Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cold and Flu Supplement Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cold and Flu Supplement Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cold and Flu Supplement Key Players Headquarters & Area Served
  7. 4.4 Global Cold and Flu Supplement Players, Product Type & Application
  8. 4.5 Global Cold and Flu Supplement Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cold and Flu Supplement Market CR5 and HHI
  11. 4.6.3 2025 Cold and Flu Supplement Tier 1, Tier 2, and Tier 3
5 Cold and Flu Supplement Market Size by Type
  1. 5.1 Global Cold and Flu Supplement Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cold and Flu Supplement Revenue by Type (2021-2032)
  3. 5.3 Global Cold and Flu Supplement Revenue Market Share by Type (2021-2032)
6 Cold and Flu Supplement Market Size by Application
  1. 6.1 Global Cold and Flu Supplement Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cold and Flu Supplement Revenue by Application (2021-2032)
  3. 6.3 Global Cold and Flu Supplement Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Pfizer
  2. 7.1.1 Pfizer Company Information
  3. 7.1.2 Pfizer Business Overview
  4. 7.1.3 Pfizer Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Cold and Flu Supplement Product Portfolio
  6. 7.1.5 Pfizer Recent Developments
  7. 7.2 GlaxoSmithKline
  8. 7.2.1 GlaxoSmithKline Company Information
  9. 7.2.2 GlaxoSmithKline Business Overview
  10. 7.2.3 GlaxoSmithKline Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  11. 7.2.4 GlaxoSmithKline Cold and Flu Supplement Product Portfolio
  12. 7.2.5 GlaxoSmithKline Recent Developments
  13. 7.3 Wakunaga of America
  14. 7.3.1 Wakunaga of America Company Information
  15. 7.3.2 Wakunaga of America Business Overview
  16. 7.3.3 Wakunaga of America Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Wakunaga of America Cold and Flu Supplement Product Portfolio
  18. 7.3.5 Wakunaga of America Recent Developments
  19. 7.4 The Vitamin Shoppe
  20. 7.4.1 The Vitamin Shoppe Company Information
  21. 7.4.2 The Vitamin Shoppe Business Overview
  22. 7.4.3 The Vitamin Shoppe Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  23. 7.4.4 The Vitamin Shoppe Cold and Flu Supplement Product Portfolio
  24. 7.4.5 The Vitamin Shoppe Recent Developments
  25. 7.5 NOW Foods
  26. 7.5.1 NOW Foods Company Information
  27. 7.5.2 NOW Foods Business Overview
  28. 7.5.3 NOW Foods Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  29. 7.5.4 NOW Foods Cold and Flu Supplement Product Portfolio
  30. 7.5.5 NOW Foods Recent Developments
  31. 7.6 Nordic Naturals
  32. 7.6.1 Nordic Naturals Company Information
  33. 7.6.2 Nordic Naturals Business Overview
  34. 7.6.3 Nordic Naturals Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Nordic Naturals Cold and Flu Supplement Product Portfolio
  36. 7.6.5 Nordic Naturals Recent Developments
  37. 7.7 Neurobiologix
  38. 7.7.1 Neurobiologix Company Information
  39. 7.7.2 Neurobiologix Business Overview
  40. 7.7.3 Neurobiologix Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Neurobiologix Cold and Flu Supplement Product Portfolio
  42. 7.7.5 Neurobiologix Recent Developments
  43. 7.8 Klaire Labs
  44. 7.8.1 Klaire Labs Company Information
  45. 7.8.2 Klaire Labs Business Overview
  46. 7.8.3 Klaire Labs Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Klaire Labs Cold and Flu Supplement Product Portfolio
  48. 7.8.5 Klaire Labs Recent Developments
  49. 7.9 Himalaya Global Holdings
  50. 7.9.1 Himalaya Global Holdings Company Information
  51. 7.9.2 Himalaya Global Holdings Business Overview
  52. 7.9.3 Himalaya Global Holdings Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Himalaya Global Holdings Cold and Flu Supplement Product Portfolio
  54. 7.9.5 Himalaya Global Holdings Recent Developments
  55. 7.10 Flora
  56. 7.10.1 Flora Company Information
  57. 7.10.2 Flora Business Overview
  58. 7.10.3 Flora Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Flora Cold and Flu Supplement Product Portfolio
  60. 7.10.5 Flora Recent Developments
  61. 7.11 FineVine
  62. 7.11.1 FineVine Company Information
  63. 7.11.2 FineVine Business Overview
  64. 7.11.3 FineVine Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  65. 7.11.4 FineVine Cold and Flu Supplement Product Portfolio
  66. 7.11.5 FineVine Recent Developments
  67. 7.12 Dr. Willmar Schwabe GmbH
  68. 7.12.1 Dr. Willmar Schwabe GmbH Company Information
  69. 7.12.2 Dr. Willmar Schwabe GmbH Business Overview
  70. 7.12.3 Dr. Willmar Schwabe GmbH Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Dr. Willmar Schwabe GmbH Cold and Flu Supplement Product Portfolio
  72. 7.12.5 Dr. Willmar Schwabe GmbH Recent Developments
8 North America
  1. 8.1 North America Cold and Flu Supplement Revenue (2021-2032)
  2. 8.2 North America Cold and Flu Supplement Revenue by Type (2021-2032)
  3. 8.2.1 North America Cold and Flu Supplement Revenue by Type (2021-2026)
  4. 8.2.2 North America Cold and Flu Supplement Revenue by Type (2027-2032)
  5. 8.3 North America Cold and Flu Supplement Revenue Share by Type (2021-2032)
  6. 8.4 North America Cold and Flu Supplement Revenue by Application (2021-2032)
  7. 8.4.1 North America Cold and Flu Supplement Revenue by Application (2021-2026)
  8. 8.4.2 North America Cold and Flu Supplement Revenue by Application (2027-2032)
  9. 8.5 North America Cold and Flu Supplement Revenue Share by Application (2021-2032)
  10. 8.6 North America Cold and Flu Supplement Revenue by Country
  11. 8.6.1 North America Cold and Flu Supplement Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cold and Flu Supplement Revenue by Country (2021-2026)
  13. 8.6.3 North America Cold and Flu Supplement Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Cold and Flu Supplement Revenue (2021-2032)
  2. 9.2 Europe Cold and Flu Supplement Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cold and Flu Supplement Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cold and Flu Supplement Revenue by Type (2027-2032)
  5. 9.3 Europe Cold and Flu Supplement Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cold and Flu Supplement Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cold and Flu Supplement Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cold and Flu Supplement Revenue by Application (2027-2032)
  9. 9.5 Europe Cold and Flu Supplement Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cold and Flu Supplement Revenue by Country
  11. 9.6.1 Europe Cold and Flu Supplement Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cold and Flu Supplement Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cold and Flu Supplement Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Cold and Flu Supplement Revenue (2021-2032)
  2. 10.2 China Cold and Flu Supplement Revenue by Type (2021-2032)
  3. 10.2.1 China Cold and Flu Supplement Revenue by Type (2021-2026)
  4. 10.2.2 China Cold and Flu Supplement Revenue by Type (2027-2032)
  5. 10.3 China Cold and Flu Supplement Revenue Share by Type (2021-2032)
  6. 10.4 China Cold and Flu Supplement Revenue by Application (2021-2032)
  7. 10.4.1 China Cold and Flu Supplement Revenue by Application (2021-2026)
  8. 10.4.2 China Cold and Flu Supplement Revenue by Application (2027-2032)
  9. 10.5 China Cold and Flu Supplement Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cold and Flu Supplement Revenue (2021-2032)
  2. 11.2 Asia Cold and Flu Supplement Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cold and Flu Supplement Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cold and Flu Supplement Revenue by Type (2027-2032)
  5. 11.3 Asia Cold and Flu Supplement Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cold and Flu Supplement Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cold and Flu Supplement Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cold and Flu Supplement Revenue by Application (2027-2032)
  9. 11.5 Asia Cold and Flu Supplement Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cold and Flu Supplement Revenue by Country
  11. 11.6.1 Asia Cold and Flu Supplement Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cold and Flu Supplement Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cold and Flu Supplement Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cold and Flu Supplement Revenue (2021-2032)
  2. 12.2 SAMEA Cold and Flu Supplement Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cold and Flu Supplement Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cold and Flu Supplement Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cold and Flu Supplement Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cold and Flu Supplement Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cold and Flu Supplement Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cold and Flu Supplement Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cold and Flu Supplement Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cold and Flu Supplement Revenue by Country
  11. 12.6.1 SAMEA Cold and Flu Supplement Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cold and Flu Supplement Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cold and Flu Supplement Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst